The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2025 | Key barriers to equitable hematologic care in India and priorities for the next decade
Rohan Halder, MBBS, MD, DM, PDCC, Rajiv Gandhi Cancer Institute, Delhi, India, outlines major challenges to equitable hematologic care in India, including late diagnosis, limited specialist access, workforce shortages, financial toxicity, and a pronounced rural–urban divide. He highlights the need for expanded screening programs, stronger disease-specific initiatives for conditions such as sickle cell disease, thalassemia, and hemophilia, improved primary-level diagnostic infrastructure, and greater availability of advanced therapies. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
